163.3K
XNAS Volume
High vol. this week
XNAS 18 Mar, 2025 2:14 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mary Kay Fenton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 03 Jul 2023 | 12,946 | 68,054 | - | 3.1 | 39,874 | Common Stock |
| Scott Requadt | Former Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 03 Jul 2023 | 11,786 | 578,403 | - | 3.1 | 36,301 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 07 Jun 2023 | 40,642 | 3,840,831 | - | 2.5 | 100,772 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.39 per share. | 07 Jun 2023 | 75,001 | 3,881,473 | - | 2.4 | 179,095 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 07 Jun 2023 | 25,419 | 3,815,412 | - | 2.5 | 62,637 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 05 Jun 2023 | 7,841 | 2,782,023 | - | 2.5 | 19,755 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 05 Jun 2023 | 25,549 | 2,756,474 | - | 2.5 | 64,596 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 01 Jun 2023 | 15,713 | 2,805,682 | - | 2.6 | 40,177 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 01 Jun 2023 | 15,818 | 2,789,864 | - | 2.5 | 39,616 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 21 Apr 2023 | 15,004 | 2,821,395 | - | 2.3 | 35,231 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.16 per share. | 19 Apr 2023 | 21,753 | 2,883,389 | - | 2.2 | 47,056 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.33 per share. | 19 Apr 2023 | 46,990 | 2,836,399 | - | 2.3 | 109,313 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 17 Apr 2023 | 49,211 | 2,905,142 | - | 2.2 | 105,804 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.14 per share. | 17 Apr 2023 | 99,771 | 2,954,353 | - | 2.1 | 213,530 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 17 Mar 2023 | 10,436 | 3,054,124 | - | 2.1 | 21,543 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 03 Mar 2023 | 6,806 | 3,064,560 | - | 2.1 | 13,992 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 01 Mar 2023 | 29 | 3,071,366 | - | 2.0 | 59 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 21 Feb 2023 | 3,500 | 3,071,395 | - | 2.1 | 7,185 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 16 Feb 2023 | 3,612 | 3,074,895 | - | 2.1 | 7,406 | Common Stock |
| Suzanne T. Ildstad | Director | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 16 Feb 2023 | 2,939 | 3,078,507 | - | 2.1 | 6,040 | Common Stock |
| Michael Zdanowski | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Appreciation Right | |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Appreciation Right | |
| Scott Requadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Scott Requadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 01 Feb 2023 | 4 | 590,193 | - | 0.8 | 3 | Common Stock |
| Michael Zdanowski | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Nancy Krieger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 120,000 | 120,000 | - | - | Stock Appreciation Right | |
| Nancy Krieger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Scott Requadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 320,000 | 320,000 | - | - | Stock Appreciation Right | |
| Michael Zdanowski | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2022 | 120,000 | 121,470 | - | 0 | Common Stock | |
| Nancy Krieger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2022 | 80,000 | 330,233 | - | 0 | Common Stock | |
| Scott Requadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2022 | 80,000 | 590,189 | - | 0 | Common Stock | |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2022 | 80,000 | 81,000 | - | 0 | Common Stock | |
| Suzanne T. Ildstad | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.80 per share. | 22 Aug 2022 | 525,000 | 3,081,446 | - | 2.8 | 1,470,000 | Common Stock |
| Scott Requadt | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 29 Jul 2022 | 39,382 | 508,680 | - | 4.3 | 167,374 | Common Stock |
| Scott Requadt | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 26 Jul 2022 | 5,528 | 466,208 | - | 4.2 | 23,439 | Common Stock |
| Scott Requadt | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 26 Jul 2022 | 3,090 | 469,298 | - | 4.3 | 13,133 | Common Stock |
| Scott Requadt | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.75 per share. | 22 Jul 2022 | 9,444 | 460,680 | - | 3.7 | 35,412 | Common Stock |
| Francois Nader | Director | Other type of transaction at price $ 0.00 per share. | 19 Jul 2022 | 138,500 | 0 | - | 0 | Common Stock | |
| Francois Nader | Director | Purchase of securities on an exchange or from another person at price $ 3.72 per share. | 19 Jul 2022 | 36,500 | 138,500 | - | 3.7 | 135,780 | Common Stock |
| Francois Nader | Director | Other type of transaction at price $ 0.00 per share. | 19 Jul 2022 | 248,432 | 248,432 | - | 0 | Common Stock | |
| Francois Nader | Director | Other type of transaction at price $ 0.00 per share. | 19 Jul 2022 | 248,432 | 147,255 | - | 0 | Common Stock | |
| Francois Nader | Director | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 19 Jul 2022 | 52,000 | 102,000 | - | 3.6 | 188,240 | Common Stock |
| Francois Nader | Director | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 19 Jul 2022 | 50,000 | 50,000 | - | 3.5 | 176,000 | Common Stock |
| Francois Nader | Director | Other type of transaction at price $ 0.00 per share. | 19 Jul 2022 | 138,500 | 386,932 | - | 0 | Common Stock | |
| Geoff Mackay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Francois Nader | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Mark D. Mcdade | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Sapna Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Sandip Agarwala | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Gaurav Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 14,501 | 14,501 | - | - | Stock Option (Right to Buy) | |
| Karen L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 29,002 | 29,002 | - | - | Stock Option (Right to Buy) | |
| Suzanne T. Ildstad | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2022 | 1,200,000 | 3,606,446 | - | 0 | Common Stock | |
| Michael Zdanowski | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 13.00 per share. | 01 Feb 2022 | 1,470 | 1,470 | - | 13 | 19,110 | Common Stock |
| Michael Zdanowski | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Nancy Krieger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Suzanne T. Ildstad | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2022 | 1,200,000 | 1,200,000 | - | 0 | Common Stock | |
| Suzanne T. Ildstad | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Scott Requadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Scott Requadt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 13.00 per share. | 01 Feb 2022 | 1,470 | 451,236 | - | 13 | 19,110 | Common Stock |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 13.00 per share. | 01 Feb 2022 | 1,000 | 1,000 | - | 13 | 13,000 | Common Stock |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Francois Nader | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2021 | 59,520 | 336,167 | - | 0 | Common Stock | |
| Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 1,271,027 | 0 | - | - | Series A-1 Preferred Stock | ||
| Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 1,308,410 | 0 | - | - | Series A Preferred Stock | ||
| Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 406,338 | 0 | - | - | Series B Preferred Stock | ||
| Sandip Agarwala | Director, Ten Percent Owner | 11 May 2021 | 2,985,775 | 2,985,775 | - | - | Common Stock | ||
| Sandip Agarwala | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 11 May 2021 | 235,000 | 3,220,775 | - | 17 | 3,995,000 | Common Stock |